Prosecution Insights
Last updated: October 04, 2026
Application No. 17/607,438

METHOD FOR TREATING COUGH BY USING DIAMINOPYRIMIDINE COMPOUND

Final Rejection
Filed
Oct 29, 2021
Priority
Apr 30, 2019 — CN PCT/CN2019/085180 +1 more
Examiner
PECKHAM, RICHARD GRANT
Art Unit
1627
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
BEIJING TIDE PHARMACEUTICAL CO., LTD.
OA Round
4 (Final)
68%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
92 granted / 135 resolved
+8.1% vs TC avg
Strong +35% interview lift
Without
With
+35.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
69 currently pending
Career history
188
Total Applications
across all art units

Statute-Specific Performance

§101
2.9%
-37.1% vs TC avg
§103
28.8%
-11.2% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
30.3%
-9.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 135 resolved cases

Prosecution Timeline

Show 3 earlier events
Jun 06, 2025
Final Rejection mailed
Nov 06, 2025
Response after Non-Final Action
Dec 08, 2025
Request for Continued Examination
Dec 09, 2025
Response after Non-Final Action
Jan 12, 2026
Non-Final Rejection mailed
May 11, 2026
Response Filed
May 11, 2026
Response after Non-Final Action
Jul 07, 2026
Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12748101
COMPOSITION AND METHOD FOR INHIBITING BORC COMPLEX TO TREAT CANCERS WITH NF1 DEFICIENCY AND DYSREGULATED RAS SIGNALING
4y 6m to grant Granted Sep 29, 2026
Patent 12735425
6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT
3y 3m to grant Granted Sep 15, 2026
Patent 12728170
COMPOUNDS CAPABLE OF BINDING TO PROTEINS AND CONJUGATES OBTAINED FROM THESE COMPOUNDS
3y 7m to grant Granted Sep 08, 2026
Patent 12724175
CONTACT LENS WITH OPTICAL PROPHYLAXIS
3y 10m to grant Granted Sep 01, 2026
Patent 12703691
PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND THEIR USE
3y 10m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+35.1%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 135 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month